Finch Therapeutics Group, Inc.
FNCH
$13.25
-$0.20-1.49%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 89.63% | 89.32% | 34.80% | 7.47% | -79.18% |
| Total Depreciation and Amortization | -95.68% | -96.46% | -72.40% | -39.63% | 5.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -96.96% | -98.18% | 31.51% | 104.62% | 820.50% |
| Change in Net Operating Assets | -1,710.73% | -273.80% | -246.55% | -1,334.43% | 93.80% |
| Cash from Operations | 67.70% | 64.07% | 57.91% | 43.43% | 19.70% |
| Capital Expenditure | 103.56% | 101.09% | 100.00% | 98.43% | 93.63% |
| Sale of Property, Plant, and Equipment | -95.51% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -91.90% | 204.20% | 160.82% | 129.64% | 114.22% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | 100.00% | 100.00% | -68,081.82% | -93,700.00% | -88,200.00% |
| Issuance of Common Stock | -- | -- | -- | -80.07% | -66.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.31% | -775.00% | -775.00% | -775.00% |
| Cash from Financing | 100.00% | 100.31% | -208.62% | -208.14% | -207.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.70% | 67.56% | 25.46% | 10.47% | -16.74% |
